BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Bioptigen Receives FDA Clearance And Two Phase II SBIR Awards; Company To Exhibit At Major Technology Conference


1/19/2007 1:08:18 PM

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Bioptigen, Inc., a Duke University Biomedical Engineering Department spin-out, has received FDA clearance to market its first generation spectral domain optical coherence tomography (SDOCT) imaging systems for imaging ocular tissue microstructure. Bioptigen systems offer non-invasive three-dimensional imaging of the retina and anterior surfaces of the eye fifty times faster than previous generation technologies, with axial resolution below six micrometers. Bioptigen systems are aimed at supporting advanced research in eye disease including glaucoma, macular degeneration, and diabetic retinopathy. Unique among competitive options, Bioptigen offers multiple scanning interfaces to support in-vivo imaging in humans and animals, as well as ex-vivo imaging of tissues. Bioptigen InVivoVue™ software provides superior image processing and maximum flexibility for the researcher.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->